Herpesvirus vectors for therapy of brain tumors. - Wikidata - wikimedia - TriplyDB

Herpesvirus vectors for therapy of brain tumors.

Herpesvirus vectors for therapy of brain tumors.

http://www.wikidata.org/entity/Q34091990

about

Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates.Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.The art of gene therapy for glioma: a review of the challenging road to the bedside Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV Recent advances and future of immunotherapy for glioblastoma.Oncolytic viruses & their specific targeting to tumour cells.Prospective therapies for high-grade glial tumours: A literature review.

P2860

Q33720628-6DFB210B-2FB1-46EA-95BC-3F1F15C7FBE1 Q35111489-E15CB876-7C98-450D-9789-492DC00F6AFE Q35760658-A98784BE-4DEF-4D1E-91A5-6A5589916B41 Q36527593-0D08BF7E-D929-4F9B-9229-BEE6D69AE494 Q37031896-2ECE93D1-D69F-4481-9DBD-1277C132FD26 Q37138701-EBCF56DD-36C2-4793-BC06-9574CF968166 Q37199661-D9CD01FE-785D-4B06-A7F8-48FDDBF3F1DC Q37239071-3AF3701E-18C2-4BC5-977B-4B03D4859EE3 Q38061306-3165F3FB-1CF9-49F5-8FD5-A07C2F88E662 Q38311111-DD0F8591-5D1F-4BA2-AA54-CC4BA091D6CB

P2860

Herpesvirus vectors for therapy of brain tumors.

http://www.wikidata.org/entity/Q34091990

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Herpesvirus vectors for therapy of brain tumors.

@ast

Herpesvirus vectors for therapy of brain tumors.

@en

Herpesvirus vectors for therapy of brain tumors.

@nl

type

label

Herpesvirus vectors for therapy of brain tumors.

@ast

Herpesvirus vectors for therapy of brain tumors.

@en

Herpesvirus vectors for therapy of brain tumors.

@nl

prefLabel

Herpesvirus vectors for therapy of brain tumors.

@ast

Herpesvirus vectors for therapy of brain tumors.

@en

Herpesvirus vectors for therapy of brain tumors.

@nl

P1433

Q34091990-2B37200F-1CF2-415C-9767-7435D5D176CE

P1476

Q34091990-11796F9F-8AC0-461C-8616-2BEC32BA23F7

P2093

Q34091990-33285F10-D80F-411D-A8FE-EF7099FFE4DB

Q34091990-73CADA56-F068-4CCE-B585-942E706EBD8F

P2860

Q34091990-03C5286D-574E-4641-BEF2-E43E865397AC

Q34091990-081E21D7-A959-47CF-BC30-A51E4F4FC578

Q34091990-0A737709-CE43-40C5-9F92-3F3362E24A8E

Q34091990-0ED4EC7A-39A4-4D7F-90B7-793462EAE93D

Q34091990-1BAFD141-67B3-4B36-83FC-84C5352D908C

Q34091990-24CA19DB-C148-46F8-9932-AAAC3CC4D09C

Q34091990-3C6DC4C2-C716-4F4A-8916-476B4A180F35

Q34091990-3E550860-77F7-42EC-B536-7F70A06E5F82

Q34091990-401F2610-6673-4B97-8626-2FE7E8D6D6CA

Q34091990-497FA415-0AFB-4C41-8DED-1DCDCDF1CBEF

P304

Q34091990-9B021EDF-F722-4A0D-948A-CBFD9201BC10

P31

Q34091990-5AC7B2DA-F8D4-4BD5-9459-C66F1424B270

P356

Q34091990-9D26B004-D64F-4D71-9CD9-DDDAE2347D90

P478

Q34091990-8C9047B1-4F6C-4ED7-9B85-CEE400A043D8

P577

Q34091990-0177E4B5-7657-4C92-9787-48DA2CE97AB3

P698

Q34091990-022A1680-6BE6-4272-93FB-D2ABB118F3BB

P932

Q34091990-7D52A7C8-3D9E-48E1-B8C5-5DC14B58C81C

P356

1874357901004010103

P1433

The open virology journal

P1476

Herpesvirus vectors for therapy of brain tumors.

@en

P2093

Jacqueline Nuss Parker

http://www.w3.org/2001/XMLSchema#string

Kevin A Cassady

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.

Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor

P304

103-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874357901004010103

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20811578

http://www.w3.org/2001/XMLSchema#string

P932

2930154

http://www.w3.org/2001/XMLSchema#string